GSK Fined $54M Over UK 'Pay-For-Delay' Deals
United Kingdom antitrust regulators on Friday announced a £37.6 million ($54.3 million) fine against GlaxoSmithKline PLC after concluding that the drugmaker orchestrated improper "pay-for-delay" deals to postpone generic versions of blockbuster...To view the full article, register now.
Already a subscriber? Click here to view full article